In The Wall Street Transcript William Blair’s Matt Phipps shares his outlook on what biotech industry companies he’s most closely monitoring for 2022 and the factors at play influencing his perspective sectorwide.
Equity Research
Matt Phipps Discusses Biotech Stocks With The Wall Street Transcript
Delivered to Your Inbox
Stay up-to-date with the latest William Blair news and insights
Our Latest News
-
ProfitSolv Has Received a Significant Strategic Investment Co-Led by FTV Capital and Existing Investor Lightyear Capital
William Blair acted as financial advisor to ProfitSolv, a portfolio company of Lightyear Capital, in connection with their significant strategic investment co-led by FTV Capital and existing investor Lightyear Capital.
-
What Keeps Employees Happy: Lessons From 11 Years of Restaurant Industry Data
Sharon Zackfia, head of consumer research at William Blair, shares insights from over a decade of Glassdoor data to reveal how culture, leadership, and operational models—not just pay—shape employee satisfaction and long-term brand success in the restaurant sector.
-